Function: Potentially involved in transport between the endoplasmic reticulum and the Golgi apparatus.
KEGG: xla:447415
UniGene: Xl.75436
ERGIC3, also known as Erv46 and ERp43, is a protein involved in transport between the endoplasmic reticulum and Golgi apparatus. While most research has focused on mammalian ERGIC3, the Xenopus laevis ortholog likely serves similar transport functions with specific adaptations for amphibian cellular physiology. ERGIC3 belongs to a family of proteins that facilitates the bidirectional transport of cargo proteins between the ER and Golgi compartments .
In mammals, ERGIC3 has been characterized as a novel tumor-related gene with abnormal expression in various cancers, including non-small cell lung cancer (NSCLC), liver cancer, and colorectal tumors . The protein's function in Xenopus would likely involve similar transport mechanisms, though potentially adapted to the unique developmental and physiological requirements of amphibians.
Methodologically, researchers investigating Xenopus ERGIC3 should consider complementary approaches:
Sequence homology analysis comparing Xenopus ERGIC3 with mammalian orthologs
Expression pattern analysis across developmental stages using qRT-PCR
Protein localization studies using immunofluorescence with cross-reactive antibodies
Successful cloning and expression of recombinant Xenopus proteins requires careful consideration of expression systems and purification strategies. Based on successful approaches with other Xenopus proteins, the following protocol is recommended:
Cloning Procedure:
Extract total RNA from Xenopus brain or liver tissue, where ERGIC3 expression is likely higher based on mammalian expression patterns
Perform reverse transcription to generate cDNA
Amplify the full-length ERGIC3 coding sequence using PCR with primers designed based on the predicted Xenopus laevis ERGIC3 sequence
Clone the PCR product into an appropriate expression vector containing a strong promoter and a purification tag
For reference, a similar approach was successful with Xenopus type I iodothyronine deiodinase, resulting in a 1.1 kb clone including a poly-A tail encoding a 252 amino acid protein .
Expression Systems to Consider:
Bacterial expression (E. coli) for protein functional studies
Mammalian cell transfection for localization and interaction studies
Cell-free systems derived from Xenopus egg extracts for native-like post-translational modifications
Multiple complementary approaches should be employed to comprehensively characterize ERGIC3 expression:
mRNA Detection:
Quantitative real-time PCR (qRT-PCR) with ERGIC3-specific primers
RNA sequencing of tissues of interest with bioinformatic analysis
Protein Detection:
Western blotting using cross-reactive antibodies or custom antibodies raised against Xenopus ERGIC3
Immunohistochemistry for tissue localization patterns
Sample Preparation Protocol:
Homogenize tissue samples in appropriate buffer (e.g., RIPA buffer with protease inhibitors)
Centrifuge at 12,000g for 10 minutes at 4°C
Collect supernatant for protein analysis
Quantify protein concentration using Bradford or BCA assay
Separate proteins by SDS-PAGE and transfer to PVDF membrane
Probe with primary antibody (potentially using antibodies generated against mammalian ERGIC3)
Visualize with appropriate secondary antibody and detection system
For qRT-PCR, the following parameters have proven effective for other Xenopus genes:
RNA extraction using TRIzol reagent
cDNA synthesis with oligo(dT) primers
SYBR Green-based qPCR with normalization to housekeeping genes (e.g., GAPDH, EF1α)
Developing specific antibodies against Xenopus ERGIC3 requires careful antigen design and validation. Based on successful antibody development against human ERGIC3, the following approach is recommended:
Antibody Development Protocol:
Design a synthetic peptide from a predicted antigenic region of Xenopus ERGIC3
Conjugate the peptide to KLH via an N-terminal cysteine (similar to the approach used for human ERGIC3)
Immunize 8-week-old BALB/c mice subcutaneously with the ERGIC3 peptide emulsified in complete Freund's adjuvant
Administer booster injections intraperitoneally with the peptide in incomplete Freund's adjuvant
Monitor antibody titer using solid-phase ELISA
Perform cell fusion when titers reach approximately 1:10,000
Screen hybridomas by ELISA and subclone positive clones multiple times
Validate antibody specificity through western blotting, immunofluorescence, and immunohistochemistry with proper controls
Antibody Validation:
Verify recognition of the native protein by western blot (expected molecular weight for ERGIC3 is approximately 50 kDa)
Confirm appropriate subcellular localization (expected to be around the Golgi apparatus and ER)
Test cross-reactivity with other Xenopus proteins
Include appropriate negative controls (e.g., pre-immune serum, isotype-matched irrelevant antibodies)
Investigating developmental expression patterns requires stage-specific analysis:
Recommended Approach:
Collect embryos at key developmental stages (blastula, gastrula, neurula, tailbud, tadpole)
Extract RNA and protein from whole embryos or dissected tissues
Perform stage-specific qRT-PCR and western blot analysis
Consider whole-mount in situ hybridization to visualize spatial expression patterns
Employ immunohistochemistry on sectioned embryos for protein localization
Data Collection Framework:
| Developmental Stage | Method | Sample Preparation | Analysis Approach |
|---|---|---|---|
| Blastula (stage 8-9) | qRT-PCR, Western blot | Whole embryo | Compare to housekeeping genes |
| Gastrula (stage 10-12) | qRT-PCR, In situ hybridization | Whole embryo | Map expression domains |
| Neurula (stage 14-20) | qRT-PCR, IHC | Sectioned embryo | Tissue-specific localization |
| Tailbud (stage 24-35) | qRT-PCR, Western blot, IHC | Dissected tissues | Quantitative comparison |
| Tadpole (stage 45+) | qRT-PCR, Western blot, IHC | Dissected organs | Relate to metamorphosis processes |
Similar to studies on Xenopus type I iodothyronine deiodinase, researchers should pay particular attention to expression changes during metamorphosis, as this represents a period of significant tissue remodeling where ER-Golgi transport may be especially important .
Investigating ERGIC3's transport function requires specialized assays:
Recommended Functional Assays:
Cargo Transport Assay: Track the movement of fluorescently-labeled cargo proteins in ERGIC3-depleted or overexpressing Xenopus cells
Brefeldin A Sensitivity Test: Determine if ERGIC3 manipulation alters cellular sensitivity to this Golgi-disrupting agent
Protein Secretion Assay: Measure secretion efficiency of model proteins in the presence/absence of functional ERGIC3
Co-immunoprecipitation: Identify ERGIC3 binding partners in Xenopus cells
FRAP Analysis: Assess protein mobility between ER and Golgi in ERGIC3-manipulated cells
Experimental Design for Cargo Transport Assay:
Express a fluorescently-tagged secretory protein in Xenopus cells
Manipulate ERGIC3 levels through RNAi knockdown or overexpression
Perform live-cell imaging to track cargo movement
Quantify transport kinetics and efficiency
This approach can be complemented by using the Xenopus oocyte or egg extract systems, which offer excellent platforms for reconstituting membrane transport processes in a near-native environment .
Given ERGIC3's identification as an immune function-related gene in mammals, its role in Xenopus immunity merits investigation:
Comparative Research Approach:
Analyze ERGIC3 expression in Xenopus immune tissues (spleen, thymus) and isolated immune cells
Compare expression patterns during immune challenges (e.g., viral or bacterial exposure)
Perform knockdown studies to assess impact on immune cell function
Investigate correlation between ERGIC3 expression and levels of immune cell infiltration
Based on mammalian studies, ERGIC3 expression shows correlation with immune cell infiltration, including B cells, CD8+ T cells, CD4+ T cells, macrophages, neutrophils, and myeloid dendritic cells . A similar analysis in Xenopus could be performed using flow cytometry to quantify immune cell populations in relation to ERGIC3 expression levels.
Experimental Design Framework:
Stimulate Xenopus immune system with appropriate challenges
Collect tissues at defined timepoints
Measure ERGIC3 expression alongside markers of immune activation
Perform functional assays on isolated immune cells with modified ERGIC3 expression
Investigating potential cell cycle roles of ERGIC3 requires specialized approaches:
Research Strategy:
Synchronize Xenopus cell cultures and analyze ERGIC3 expression across cell cycle phases
Perform knockdown or overexpression studies and assess impact on cell cycle progression
Investigate ERGIC3 interaction with known cell cycle regulators
Employ Xenopus egg extracts to study ERGIC3 function during mitosis
The Xenopus egg system is particularly valuable for cell cycle studies as demonstrated by research on Aurora B kinase, which affects cytoskeletal dynamics during cell division . Similar approaches could reveal whether ERGIC3 influences membrane dynamics during cell division.
Experimental Considerations:
Use synchronized XTC or A6 Xenopus cell lines
Employ flow cytometry to assess cell cycle distribution
Visualize ERGIC3 localization during different cell cycle stages
Consider potential interactions with cell cycle checkpoint proteins
Based on findings that human ERGIC3 is regulated by miR-203a , similar regulatory mechanisms may exist in Xenopus:
Comprehensive Approach:
Bioinformatic Prediction: Use algorithms such as RNAhybrid and miRecords to identify potential miRNA binding sites in Xenopus ERGIC3 mRNA
Expression Correlation: Analyze expression patterns of predicted miRNAs and ERGIC3 across tissues and developmental stages
Luciferase Reporter Assay: Clone the ERGIC3 3'UTR into a reporter construct to test miRNA binding functionality
miRNA Manipulation: Perform gain and loss of function studies with identified miRNAs
Protocol for Luciferase Reporter Assay:
Clone the 3'UTR of Xenopus ERGIC3 into a dual-luciferase reporter vector
Co-transfect the reporter construct with miRNA mimics or inhibitors
Measure luciferase activity 48-72 hours post-transfection
Compare with mutated binding site controls
For miRNA expression profiling, the following approach has proven effective:
Extract total RNA using a miRNA-preserving method
Prepare cDNA using a miScript II RT Kit
Perform qRT-PCR with miScript SYBR Green PCR Kit
Understanding ERGIC3's functional network requires integrated approaches:
Multi-omics Strategy:
RNA-seq: Compare transcriptomes of ERGIC3-depleted and control Xenopus cells/tissues
Quantitative Proteomics: Perform LC-MS/MS analysis of protein changes following ERGIC3 manipulation
Protein-Protein Interaction Analysis: Use co-immunoprecipitation coupled with mass spectrometry to identify binding partners
Network Analysis: Map identified interactions using bioinformatic tools like STRING and Cytoscape
For RNA-seq analysis, the following parameters have been effective:
Filter reads with SOAPnuke v1.5.2
Map clean reads to reference genome using HISAT2 v2.0.4
Identify differentially expressed genes using DEseq2 (Fold Change ≥ 2.00 and Adjusted P value ≤0.05)
For protein interaction network analysis:
Map differentially expressed genes/proteins to the STRING database
Visualize the PPI network using Cytoscape 3.8.0
Analyze network topology using the Analyze Network plugin
Screen modules within the PPI network using MCODE plugin with parameters: degree cutoff = 2, node score cutoff = 0.2, k-score = 2, max.depth = 100
This approach can identify hub genes and functional modules related to ERGIC3, providing insights into its broader functional role in Xenopus cells.